Drug details

Bydureon (exenatide)

type of Antidiabetics, Glucagon-like Peptide-1 Agonists

Bydureon (exenatide) is an incretin mimetic, which improves blood sugar control by mimicking the action of a hormone called glucagon-like peptide 1 (GLP-1), indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

This drug may have the following side effects:

• headache,
• vomiting,
• diarrhea,
• constipation,
• nausea (especially when you first start using Bydureon),
• itching at the injection site,
• a small bump (nodule) at the injection site, and
• indigestion.

The following drugs are related to Bydureon, either as a replacement or used together:

• Accupril (quinapril hydrochloride)
• Brenzavvy (bexagliflozin tablets)
• Byetta (exenatide injection)
• Diabinese (chlorpropamide)
• Farxiga (dapagliflozin film-coated tablets)
• Qternmet XR (dapagliflozin, saxagliptin, and metformin hydrochloride)
• DiaBeta (glyburide tablets)
• Trulicity (dulaglutide injection, for subcutaneous use)
• Glucotrol (glipizide)
• Glucotrol XL (glipizide extended release)
• Glucovance (glyburide and metformin)
• Humalog (insulin lispro (human analog))
• Humalog 75-25 (75-25 insulin lispro suspension and 25 insulin lispro injection)
• Humalog Mix 50-50 (insulin lispro)
• Starlix Tablet (nateglinide)